創新醫療(002173.SZ):同意建華醫院公開掛牌轉讓雙華醫院100%股權
格隆匯8月1日丨創新醫療(002173.SZ)公佈,公司第六屆董事會於2024年8月1日召開了2024年第五次臨時會議,審議通過了《關於同意建華醫院公開掛牌轉讓雙華醫院100%股權的議案》。
齊齊哈爾建華醫院有限責任公司(以下簡稱"建華醫院")為了提高資產經營能力和運營質量,對虧損業務單元及時止損並盤活存量資產,擬在黑龍江聯合產權交易所公開掛牌轉讓哈爾濱雙華醫院有限公司(以下簡稱"雙華醫院")100%股權。本次拍賣的掛牌底價以雙華醫院最近一期經審計淨資產賬面價值為參考依據,不低於人民幣511.64萬元,具體交易價格將按公開掛牌競價結果確定。如因流拍而再次掛牌拍賣的,起拍價不低於上次起拍價的80%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.